Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can preoperative PSA doubling time and PSA velocity predict outcomes following radical prostatectomy?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Thompson IM et al. (2004) Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med 350: 2239–2246

    Article  CAS  Google Scholar 

  2. Carter HB and Pearson JD (1993) PSA velocity for the diagnosis of early prostate cancer. A new concept. Urol Clin North Am 20: 665–670

    CAS  PubMed  Google Scholar 

  3. Pound CR et al. (1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281: 1591–1597

    Article  CAS  Google Scholar 

  4. Freedland SJ et al. (2005) Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 294: 433–439

    Article  CAS  Google Scholar 

  5. D'Amico AV et al. (2004) Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 351: 125–135

    Article  CAS  Google Scholar 

  6. Egawa S et al. (2000) Use of pretreatment prostate specific antigen doubling time to predict outcome after radical prostatectomy. Prostate Cancer Prostatic Dis 3 (Suppl 1): S11

    Article  CAS  Google Scholar 

  7. Goluboff ET et al. (1997) Pretreatment prostate specific antigen doubling times: use in patients before radical prostatectomy. J Urol 158: 1876–1879

    Article  CAS  Google Scholar 

  8. Freedland SJ et al. (2001) Preoperative PSA velocity and doubling time do not predict adverse pathologic features or biochemical recurrence after radical prostatectomy. Urology 57: 476–480

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Sandra Ford, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gerald L Andriole.

Ethics declarations

Competing interests

Dr Andriole is the Principal Investigator and Chairman of the Prostate Committee of PLCO, an NCI-sponsored long-term trial assessing the role of PSA testing in screening.

Dr Grubb is an Investigator for the Prostate Committee of the PLCO.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grubb, R., Andriole, G. Can preoperative PSA doubling time and PSA velocity predict outcomes following radical prostatectomy?. Nat Rev Urol 3, 306–307 (2006). https://doi.org/10.1038/ncpuro0476

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0476

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing